Author

Norman M. Bleehen

Observed names: N M Bleehen, N. M. Bleehen, NM BLEEHEN, NM Bleehen, Norman Bleehen, Norman M Bleehen

Institutions: University of London, Hammersmith Hospital, Addenbrooke's Hospital, Imperial College London, Medical Research Council

Observed institutions: University of London, University of Cambridge, Mount Vernon Hospital, Hammersmith Hospital, Charing Cross Hospital, MRC Cancer Unit, Cancer Research UK Scotland Institute, Velindre Cancer Centre, Addenbrooke's Hospital, Imperial College London, All India Institute of Medical Sciences, University of Glasgow, Medical Research Council

OpenAlex ID: A5113799448

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma

1991 · NM Bleehen, SP Stenning · British Journal of Cancer · 421

PDF

A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status

1992 · NM Bleehen, DJ Girling, et al. · British Journal of Cancer · 303

PDF

Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin A

1991 · Peter R. Twentyman, Norman M. Bleehen · European Journal of Cancer and Clinical Oncology · 212

A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma

2000 · Graham M. Mead, Norman M. Bleehen, et al. · Cancer · 208

Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme

1993 · Alphonse Taghian, Jonathan Ramsay, et al. · International Journal of Radiation Oncology*Biology*Physics · 113

Expression of apoptosis-regulatory genes in lung tumour cell lines: relationship to p53 expression and relevance to acquired drug resistance

1996 · JG Reeve, J Xiong, et al. · British Journal of Cancer · 87

PDF

Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours

1991 · V Sundaresan, JG Reeve, et al. · British Journal of Cancer · 84

PDF

Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma

1989 · DJ Kerr, T Maughan, et al. · British Journal of Cancer · 83

PDF

Pharmacokinetic Evaluation of N-[2-(Dimethylamino)Ethyl]Acridine-4-Carboxamide in Patients by Positron Emission Tomography

2001 · Azeem Saleem, Robert J. Harte, et al. · Journal of Clinical Oncology · 80

A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life

1993 · NM Bleehen, DJ Girling, et al. · British Journal of Cancer · 70

PDF

Experimental and Clinical Aspects of Hyperthermia Applied to the Treatment of Cancer with Special Reference to the Role of Ultrasonic and Microwave Heating

1976 · Isaac Har-Kedar, Norman M. Bleehen · Advances in radiation biology · 70

Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party

1991 · PM Fayers, NM Bleehen, et al. · British Journal of Cancer · 67

PDF

Complications of Cancer Management

1991 · Norman M Bleehen · British Journal of Cancer · 58

Clinical pharmacokinetics of oral CCNU (Lomustine)

1985 · Francis Y. F. Lee, Paul Workman, et al. · Cancer Chemotherapy and Pharmacology · 57

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis

1996 · NM Bleehen, DJ Girling, et al. · British Journal of Cancer · 55

Production of immunoreactive insulin-like growth factor-I (IGF-I) and IGF-I binding proteins by human lung tumours

1990 · JG Reeve, JA Payne, et al. · British Journal of Cancer · 50

Drug resistance in human lung cancer cell lines: Cross-resistance studies and effects of the calcium transport blocker, verapamil

1986 · Peter R. Twentyman, Norma E. Fox, et al. · International Journal of Radiation Oncology*Biology*Physics · 49

A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors

1993 · NM Bleehen, DJ Girling, et al. · British Journal of Cancer · 47

PDF

Pentoxifylline: its pharmacokinetics and ability to improve tumour perfusion and radiosensitivity in mice

1993 · Davina J. Honess, Ian F. Dennis, et al. · Radiotherapy and Oncology · 40

Radiotherapy for lung cancer

1985 · Norman M. Bleehen, James D. Cox · International Journal of Radiation Oncology*Biology*Physics · 39

Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients

1995 · VM Laurence, R Ward, et al. · British Journal of Cancer · 34

A phase I study of the combination of two hypoxic cell radiosensitizers, Ro 03-8799 and SR-2508: Toxicity and pharmacokinetics

1986 · Hugh F.V. Newman, Norman M. Bleehen, et al. · International Journal of Radiation Oncology*Biology*Physics · 32

Perfusion changes in the RIF-1 tumour and normal tissues after carbogen and nicotinamide, individually and combined

1995 · DJ Honess, NM Bleehen · British Journal of Cancer · 30

PDF

Insulin‐like growth‐factor‐binding protein gene expression and protein production by human tumour cell lines

1992 · Julie G. Reeve, Lemuel B. Kirby, et al. · International Journal of Cancer · 30

A Pilot Study of Idiotypic Vaccination for Follicular B-cell Lymphoma Using a Genetic Approach. University of Bristol, Bristol, United Kingdom

1997 · Robert E. Hawkins, Stephen J. Russell, et al. · Human Gene Therapy · 29

Works count: 92

Citation count: 2,899

H-index: 26

I10-index: 50